MULTISPEZIFISCHE ANTIGEN BINDENDE PROTEINE

Patent europeic · EP3313876 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3313876
Numer da la dumonda
EP16733394
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
23-06-2016
Publitgà
02-05-2018
Concedì
22-01-2025
La protecziun finescha il pli tard
22-06-2036
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07K 16/00 (2006.01)
C07K 16/28 (2006.01)
C07K 16/46 (2006.01)
Prioritad
WO PCT/EP2015/064070 23.06.2015
US 201562271491 P 28.12.2015
Dumonda PCT
PCT/EP2016/064528 23.06.2016
Publicaziun PCT
WO2016/207273 29.12.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 03-12-2025

    Midada

    Published in Swissreg on 03.12.2025

  3. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  4. 22-01-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.01.2025

Partidas

Possessur

Innate Pharma

117, Avenue de Luminy, 13009 Marseille, FR

Inventur

GAUTHIER, Laurent

13008 Marseille, FR

ROSSI, Benjamin

13008 Marseille, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.